Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma
Public ClinicalTrials.gov record NCT04046939. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Biomarker Study of the Effects of Dexpramipexole on Eosinophils in Subjects With Eosinophilic Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, placebo-controlled, parallel-group, dose-ranging, multi-center study to evaluate the clinical effects of oral administration of dexpramipexole for 12 weeks on peripheral blood eosinophil count in subjects with eosinophilic asthma.
Study identification
- NCT ID
- NCT04046939
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 534 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 74 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 15, 2019 (Actual)
- Primary completion
- Dec 3, 2020 (Actual)
- Completion
- Mar 2, 2021 (Actual)
- Last update posted
- Apr 13, 2023
2019 – 2021
United States locations
- U.S. sites
- 36
- U.S. states
- 18
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Los Angeles | California | 90048 | — |
| Research Site | Mission Viejo | California | 92691 | — |
| Research Site | Westminster | California | 92683 | — |
| Research Site | Denver | Colorado | 80230 | — |
| Research Site | Daytona Beach | Florida | 32117 | — |
| Research Site | Miami | Florida | 33186 | — |
| Research Site | Orlando | Florida | 32803 | — |
| Research Site | Tampa | Florida | 33612 | — |
| Research Site | Tampa | Florida | 33634 | — |
| Research Site | Lawrenceville | Georgia | 30046 | — |
| Research Site | Winder | Georgia | 30680 | — |
| Research Site | Boise | Idaho | 83706 | — |
| Research Site | Farmington Hills | Michigan | 48336 | — |
| Research site | Plymouth | Minnesota | 55441 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Las Vegas | Nevada | 89119 | — |
| Research Site | New Brunswick | New Jersey | 08901 | — |
| Research Site | Corning | New York | 14830 | — |
| Research Site | New Hyde Park | New York | 11042 | — |
| Research Site | Raleigh | North Carolina | 27607 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Cincinnati | Ohio | 45231 | — |
| Research Site | Cincinnati | Ohio | 45242 | — |
| Research Site | Columbus | Ohio | 43235 | — |
| Research Site | Dublin | Ohio | 43016 | — |
| Research Site | Edmond | Oklahoma | 73034 | — |
| Research Site | Medford | Oregon | 97504 | — |
| Research Site | Portland | Oregon | 97202 | — |
| Research Site | Pittsburgh | Pennsylvania | 15205 | — |
| Research Site | Anderson | South Carolina | 29621 | — |
| Research Site | North Charleston | South Carolina | 29406 | — |
| Research Site | Allen | Texas | 75013 | — |
| Research Site | Boerne | Texas | 78006 | — |
| Research Site | Dallas | Texas | 75240 | — |
| Research Site | El Paso | Texas | 79902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04046939, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2023 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04046939 live on ClinicalTrials.gov.